文献速递心境障碍

氯胺酮经突触前腺苷A1受体减少神经元释放谷氨酸

Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors.
PubMed 文献 · Mol Psychiatry · 2021-08-11

该研究在啮齿类动物中采用FAST技术、突触体和原代皮层神经元,检测氯胺酮及其代谢物(2R,6R)-HNK对神经元源性谷氨酸释放的影响。结果显示两者均减少谷氨酸释放,该效应可被AMPA受体拮抗和腺苷A1受体拮抗所阻断,并伴随P-T286-CamKII与P-S9-Synapsin降低。系统给予A1R拮抗剂可抵消氯胺酮及(2R,6R)-HNK在强迫游泳试验中的抗抑郁样作用。

要点

  • 氯胺酮及(2R,6R)-HNK减少神经元源性谷氨酸释放,该效应依赖AMPA受体。
  • 腺苷A1受体拮抗可抵消氯胺酮对谷氨酸释放和突触前活动的抑制。
  • 系统给予A1R拮抗剂抵消氯胺酮及(2R,6R)-HNK的抗抑郁样行为效应。

核心结论

  • 研究识别出一种逆行腺苷能反馈机制,介导氯胺酮对谷氨酸释放的抑制作用,可能参与其快速抗抑郁作用。

研究设计与样本

  • 在啮齿类动物中,采用FAST法在自由活动或麻醉动物体内测量去极化诱发的细胞外谷氨酸水平。
  • 采用突触体检测离体突触再循环,采用原代皮层神经元进行功能成像和体外细胞内信号研究。

主要发现

  • 氯胺酮和(2R,6R)-HNK在多种方法中均减少谷氨酸释放,且可被AMPA受体拮抗阻断。
  • 腺苷A1受体拮抗可抵消氯胺酮对谷氨酸释放和突触前活动的效应。
  • 原代神经元培养中,氯胺酮降低P-T286-CamKII和P-S9-Synapsin,与突触小泡再循环减少相关。
  • 系统给予A1R拮抗剂可抵消氯胺酮和(2R,6R)-HNK在强迫游泳试验中的抗抑郁样作用。

关键数值与推荐

  • 氯胺酮和(2R,6R)-HNK减少去极化诱发的细胞外谷氨酸水平,该效应可被AMPA受体拮抗阻断。
  • 腺苷A1受体拮抗 counteracted 氯胺酮对谷氨酸释放及突触前活动的效应。
  • 氯胺酮降低P-T286-CamKII和P-S9-Synapsin,并与突触小泡再循环减少相关。
  • 系统给予A1R拮抗剂抵消氯胺酮和(2R,6R)-HNK在强迫游泳试验中的抗抑郁样作用。

临床怎么用

  • 该机制提示腺苷A1受体信号可能参与氯胺酮快速抗抑郁效应,为机制研究提供靶点线索。
  • 目前证据来自啮齿类动物和离体/体外实验,尚不能直接转化为精神科临床用药建议。

局限性

  • 研究在啮齿类动物及离体/体外体系中进行,结果向人类MDD患者的外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ketamine produces a rapid antidepressant response in patients with major depressive disorder (MDD), but the underlying mechanisms appear multifaceted. One hypothesis, proposes that by antagonizing NMDA receptors on GABAergic interneurons, ketamine disinhibits afferens to glutamatergic principal neurons and increases extracellular glutamate levels. However, ketamine seems also to reduce rapid glutamate release at some synapses. Therefore, clinical studies in MDD patients have stressed the need to identify mechanisms whereby ketamine decreases presynaptic activity and glutamate release. In the present study, the effect of ketamine and its antidepressant metabolite, (2R,6R)-HNK, on neuronally derived glutamate release was examined in rodents. We used FAST methodology to measure depolarization-evoked extracellular glutamate levels in vivo in freely moving or anesthetized animals, synaptosomes to detect synaptic recycling ex vivo and primary cortical neurons to perform functional imaging and to examine intracellular signaling in vitro. In all these versatile approaches, ketamine and (2R,6R)-HNK reduced glutamate release in a manner which could be blocked by AMPA receptor antagonism. Antagonism of adenosine A1 receptors, which are almost exclusively expressed at nerve terminals, also counteracted ketamine's effect on glutamate release and presynaptic activity. Signal transduction studies in primary neuronal cultures demonstrated that ketamine reduced P-T286-CamKII and P-S9-Synapsin, which correlated with decreased synaptic vesicle recycling. Moreover, systemic administration of A1R antagonist counteracted the antidepressant-like actions of ketamine and (2R,6R)-HNK in the forced swim test. To conclude, by studying neuronally released glutamate, we identified a novel retrograde adenosinergic feedback mechanism that mediate inhibitory actions of ketamine on glutamate release that may contribute to its rapid antidepressant action.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lazarevic V, Yang Y, Flais I, et al. Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors. Mol Psychiatry. 2021. PMID: 34376822. doi:10.1038/s41380-021-01246-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。